Hofseth BioCare ASA (OSL:HBC) Cash per Share: kr0.21 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:HBC Hofseth BioCare ASA OSL:HBC
61 GF Score
Price kr1.35
GF Value kr1.88
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hofseth BioCare ASA Cash per Share?

Hofseth BioCare ASA OSL:HBC +2.27% 61 Cash per Share is kr0.21 as of Jun. 2026. GuruFocus rates OSL:HBC with a GF Score™ of 61/100 and a GF Value™ of kr1.88 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Hofseth BioCare ASA's Cash per Share for the quarter that ended in Jun. 2026 was kr0.21.

Hofseth BioCare ASA  (OSL:HBC) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Hofseth BioCare ASA Cash per Share Related Terms

Hofseth BioCare ASA Cash per Share Historical Data

* Premium members only.

The historical data trend for Hofseth BioCare ASA's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hofseth BioCare ASA Cash per Share Chart

Hofseth BioCare ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.08 0.05 0.06 0.16

Hofseth BioCare ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.17 0.16 0.12 0.21
OSL:HBC
61GF Score
Hofseth BioCare ASA OSL:HBC
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hofseth BioCare ASA Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Hofseth BioCare ASA's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=63.277/395.1
=0.16

Hofseth BioCare ASA's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=107.977/506.2
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of kr0.21 mean?
Hofseth BioCare ASA (OSL:HBC) has a Cash per Share of kr0.21 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Hofseth BioCare ASA and its competitors.
Is Hofseth BioCare ASA's Cash per Share too high?
Hofseth BioCare ASA's current Cash per Share is kr0.21. Overall, Hofseth BioCare ASA has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hofseth BioCare ASA's Cash per Share compare to KHC and GIS?
Hofseth BioCare ASA's Cash per Share of kr0.21 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Consumer Packaged Goods company?
A good Cash per Share depends on the Consumer Packaged Goods industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Hofseth BioCare ASA and its competitors. Hofseth BioCare ASA's current Cash per Share is kr0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hofseth BioCare ASA stock overvalued right now?
Based on GuruFocus' analysis, Hofseth BioCare ASA (OSL:HBC) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.88, compared to a current price of kr1.35 — trading 28.2% below its estimated fair value. The current Cash per Share is kr0.21. Hofseth BioCare ASA's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Hofseth BioCare ASA (OSL:HBC), the current Cash per Share is kr0.21 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hofseth BioCare ASA (OSL:HBC) Overvalued in 2026?

Based on GuruFocus' analysis, Hofseth BioCare ASA stock appears to be undervalued. The current stock price of kr1.35 is trading 28.2% below its estimated GF Value™ of kr1.88. GuruFocus considers Hofseth BioCare ASA to be Modestly Undervalued.

Key valuation signals for OSL:HBC:

  • Cash per Share: kr0.21
  • GF Value™: kr1.88 vs. price of kr1.35 (28.2% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the OSL:HBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hofseth BioCare ASA Business Description

Address Keiser Wilhelmsgate 24, Aalesund, NOR, 6003
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
61GF Score

Get the complete analysis for OSL:HBC

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.35
Price
kr1.88
GF Value